Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isma Benattia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Drug Safety|April 22, 2016
The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety OrganizationMeredith Y Smith, Isma Benattia
The Journal of Clinical Psychiatry|January 24, 2006
Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorderKurt Kroenke, Nicholas Messina, Isma Benattia, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Structured Benefit-Risk Assessment Across the Product Lifecycle: Practical ConsiderationsMeredith Y Smith, Isma Benattia, Carmit Strauss, et al.
Psychopharmacology|January 15, 2005
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment studyShlomo Brook, Jeorg Walden, Isma Benattia, et al.
The Journal of Clinical Psychiatry|January 12, 2005
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trialDonald E N Addington, Christos Pantelis, Mary Dineen, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled studyJonathan Davidson, Barbara O Rothbaum, Phebe Tucker, et al.
Biological Psychiatry|September 25, 2007
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIsCharles B Nemeroff, Richard Entsuah, Isma Benattia, et al.
Archives of General Psychiatry|October 4, 2006
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trialJonathan Davidson, David Baldwin, Dan J Stein, et al.
International Clinical Psychopharmacology|August 16, 2008
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience ScaleJonathan Davidson, David S Baldwin, Dan J Stein, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drug Safety|April 22, 2016
The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety OrganizationMeredith Y Smith, Isma Benattia
The Journal of Clinical Psychiatry|January 24, 2006
Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorderKurt Kroenke, Nicholas Messina, Isma Benattia, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Structured Benefit-Risk Assessment Across the Product Lifecycle: Practical ConsiderationsMeredith Y Smith, Isma Benattia, Carmit Strauss, et al.
Psychopharmacology|January 15, 2005
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment studyShlomo Brook, Jeorg Walden, Isma Benattia, et al.
The Journal of Clinical Psychiatry|January 12, 2005
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trialDonald E N Addington, Christos Pantelis, Mary Dineen, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled studyJonathan Davidson, Barbara O Rothbaum, Phebe Tucker, et al.
Biological Psychiatry|September 25, 2007
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIsCharles B Nemeroff, Richard Entsuah, Isma Benattia, et al.
Archives of General Psychiatry|October 4, 2006
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trialJonathan Davidson, David Baldwin, Dan J Stein, et al.
International Clinical Psychopharmacology|August 16, 2008
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience ScaleJonathan Davidson, David S Baldwin, Dan J Stein, et al.
Pageof 1